Schedule 13G ownership disclosure

Zenas Biopharma Inc

Security class unavailable · CUSIP: 98937L105

Event date: 2024-09-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-24-000733
Form type
SC 13G
Filer
NEA 18 Venture Growth Equity, L.P.
CIK
CIK 1880239
Filed
Sep 25, 2024
Reporting period
Sep 16, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub